Evidence map›Paper›PMID 34377376›Full record

ArticleJournal of extracellular vesicles2021

Quantification of protein cargo loading into engineered extracellular vesicles at single-vesicle and single-molecule resolution.

Andreia M Silva, Elisa Lázaro-Ibáñez, Anders Gunnarsson, Aditya Dhande, George Daaboul, Ben Peacock, Xabier Osteikoetxea, Nikki Salmond, Kristina Pagh Friis, Olga Shatnyeva and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of extracellular vesicles, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 127 papers.

0numbers the graph read from it
0cells of the map it votes in
127citing papers in PubMed
9.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

127 citing papers in PubMed, 184 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Extracellular vesicles: Navigating new frontiers in glioblastoma therapy.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Review
  6. Review
  7. Endogenous Engineering Reprograms Extracellular Vesicles for Enhanced Therapeutic Function.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. HBEGF/EGFR pathway activation by hUC-MSCs improves cognitive outcomes in anti-NMDAR encephalitis.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  17. Review
  18. Article
  19. Article
  20. Review

67 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 8 countries.

Andreia M SilvaDiscovery Biology Discovery Sciences BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden.ORCID 0000-0001-6365-1407
Elisa Lázaro-IbáñezDiscovery Biology Discovery Sciences BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden.ORCID 0000-0002-3542-7069
Anders GunnarssonStructure and Biophysics Discovery Sciences BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden.ORCID 0000-0002-6334-9520
Aditya DhandeNanoView Biosciences Boston Massachusetts USA.
George DaaboulNanoView Biosciences Boston Massachusetts USA.
Ben PeacockNanoFCM INC. Nottingham UK.
Xabier OsteikoetxeaDiscovery Biology Discovery Sciences BioPharmaceuticals R&D AstraZeneca Alderley Park UK.ORCID 0000-0003-3628-0174
Nikki SalmondDiscovery Biology Discovery Sciences BioPharmaceuticals R&D AstraZeneca Alderley Park UK.ORCID 0000-0001-5126-5592
Kristina Pagh FriisAdvanced Drug Delivery Pharmaceutical Sciences BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden.ORCID 0000-0002-3432-9360
Olga ShatnyevaDiscovery Biology Discovery Sciences BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden.ORCID 0000-0003-1524-9899
Niek DekkerDiscovery Biology Discovery Sciences BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden.ORCID 0000-0001-8245-6041
AstraZeneca (Japan) · JPAstraZeneca (United Kingdom) · GBPrecision BioSciences (United States) · USAstraZeneca (Australia) · AUAstraZeneca (Italy) · ITInternational Mining Consultants · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracellular Vesicles (EVs) have been intensively explored for therapeutic delivery of proteins. However, methods to quantify cargo proteins loaded into engineered EVs are lacking. Here, we describe a workflow for EV analysis at the single-vesicle and single-molecule level to accurately quantify the efficiency of different EV-sorting proteins in promoting cargo loading into EVs. Expi293F cells were engineered to express EV-sorting proteins fused to green fluorescent protein (GFP). High levels of GFP loading into secreted EVs was confirmed by Western blotting for specific EV-sorting domains, but quantitative single-vesicle analysis by Nanoflow cytometry detected GFP in less than half of the particles analysed, reflecting EV heterogeneity. Anti-tetraspanin EV immunostaining in ExoView confirmed a heterogeneous GFP distribution in distinct subpopulations of CD63

Indexed as

Protein TransportBiological TransportCell LineDrug Delivery SystemsExosomesExtracellular VesiclesGenetic EngineeringGreen Fluorescent ProteinsHumansNanotechnologyRecombinant Fusion ProteinsTetraspaninsWorkflowGreen Fluorescent ProteinsRecombinant Fusion ProteinsTetraspaninsEV cargo sortingexosomesExoViewextracellular vesiclesnanoflow cytometryprotein delivery vehiclesingle‐molecule localization microscopy

Identifiers

PMID34377376
PMCPMC8329990
OpenAlexW3188659093

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.